These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10997771)

  • 1. Oral contraceptives, hormone replacement therapy and haemostasis.
    Conard J; Samama MM
    Cephalalgia; 2000 Apr; 20(3):175-82. PubMed ID: 10997771
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraceptives, hormone replacement therapy and thrombosis.
    Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Thromb Haemost; 2001 Jul; 86(1):112-23. PubMed ID: 11486996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal treatment in women and thrombosis].
    Kaaja R; Heikinheimo O; Rasi V
    Duodecim; 1999; 115(11):1235-43. PubMed ID: 11877844
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of venous thrombosis with hormone-replacement therapy.
    Vandenbroucke JP; Helmerhorst FM
    Lancet; 1996 Oct; 348(9033):972. PubMed ID: 8855846
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral Contraceptives and HRT Risk of Thrombosis.
    Gialeraki A; Valsami S; Pittaras T; Panayiotakopoulos G; Politou M
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):217-225. PubMed ID: 28049361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of progestogens on hemostasis.
    Skouby SO; Sidelmann JJ
    Horm Mol Biol Clin Investig; 2018 Nov; 37(2):. PubMed ID: 30447140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of hormonal therapy related thrombosis.
    Sandset PM
    Thromb Res; 2013 Jan; 131 Suppl 1():S4-7. PubMed ID: 23452740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of progestins on cardiovascular diseases: the haemostatic system.
    Winkler UH
    Hum Reprod Update; 1999; 5(3):200-4. PubMed ID: 10438102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of multiple thromboses: review of the cardiovascular complications of oral contraceptives].
    Hanssen C; Gaspard U
    Rev Med Liege; 1984 Jun; 39(11):495-9. PubMed ID: 6463475
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy.
    Bork K; Fischer B; Dewald G
    Am J Med; 2003 Mar; 114(4):294-8. PubMed ID: 12681457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives and the risk of breast cancer.
    Grant EC
    N Engl J Med; 2002 Oct; 347(18):1448-9; author reply 1448-9. PubMed ID: 12418035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
    Canonico M; Scarabin PY
    Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormone replacement therapy in menopause, hemostasis and thromboembolic risk].
    Levesque H; Cailleux N; Courtois H
    J Mal Vasc; 1994; 19(2):93-7. PubMed ID: 8077869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal control of conception.
    Tejuja S
    Indian J Physiol Pharmacol; 1972 Jan; 16(1):15-21. PubMed ID: 5025960
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral contraception.
    Hill H
    Practitioner; 1970 Jul; 205(225):5-12. PubMed ID: 4920938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.